Coagulation factor concentrates by continuous infusion
- 31 January 1997
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 11 (1), 56-63
- https://doi.org/10.1016/s0887-7963(97)80010-7
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Treatment of haemophilia A by continuous Factor VIII infusionAustralian and New Zealand Journal of Medicine, 1995
- Stability of factor VIII concentrates after reconstitutionAmerican Journal of Hematology, 1994
- Continuous infusion of monoclonal antibody-purified factor VIII: Rational approach to serious hemorrhage in patients with allo-/autoantibodies to factor VIIIAmerican Journal of Hematology, 1994
- Treatment with a pure factor IX concentrate in a patient with moderate hemophilia B undergoing bilateral total hip replacementTransfusion, 1993
- Continuous infusion of monoclonal antibody‐purified factor VIIIAmerican Journal of Hematology, 1991
- The use of continuous infusion of factor concentrates in the treatment of hemophiliaAmerican Journal of Hematology, 1989
- Induction of Immune Tolerance in Patients with Hemophilia and Antibodies to Factor VIII by Combined Treatment with Intravenous IgG, Cyclophosphamide, and Factor VIIINew England Journal of Medicine, 1988
- Fatal Myocardial Necrosis Associated with Prothrombin-Complex–Concentrate Therapy in Hemophilia ANew England Journal of Medicine, 1983
- Acute myocardial infarction in a young hemophiliac patient during therapy with Factor IX concentrate and epsilon aminocaproic acidThe Journal of Pediatrics, 1981
- Continuous Intravenous Infusion of Factor VIII in Classic HaemophiliaBritish Journal of Haematology, 1970